These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14990720)

  • 41. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
    Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
    Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection.
    Rutigliano JA; Graham BS
    J Immunol; 2004 Sep; 173(5):3408-17. PubMed ID: 15322205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein.
    Brandenburg AH; de Waal L; Timmerman HH; Hoogerhout P; de Swart RL; Osterhaus AD
    J Virol; 2000 Nov; 74(21):10240-4. PubMed ID: 11024156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
    Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
    Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope.
    Zeng RH; Gong W; Fan CF; Wang YF; Mei XG
    Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus.
    Huck B; Neumann-Haefelin D; Schmitt-Graeff A; Weckmann M; Mattes J; Ehl S; Falcone V
    Respir Res; 2007 Jan; 8(1):6. PubMed ID: 17257445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Allo-cytotoxic T lymphocyte responses in corneal allografted mice treated with monoclonal antibodies to adhesion molecules].
    Hori J; Isobe M; Mizuochi T; Yamagami S; Tsuru T
    Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):582-6. PubMed ID: 8810232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection.
    Durant LR; Pereira C; Boakye A; Makris S; Kausar F; Goritzka M; Johansson C
    Eur J Immunol; 2014 Aug; 44(8):2340-8. PubMed ID: 24777856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
    Hommel-Berrey G; Bochan M; Brahmi Z
    Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutting Edge: Oseltamivir decreases T cell GM1 expression and inhibits clearance of respiratory syncytial virus: potential role of endogenous sialidase in antiviral immunity.
    Moore ML; Chi MH; Zhou W; Goleniewska K; O'Neal JF; Higginbotham JN; Peebles RS
    J Immunol; 2007 Mar; 178(5):2651-4. PubMed ID: 17312105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.
    Martinez-Sobrido L; Gitiban N; Fernandez-Sesma A; Cros J; Mertz SE; Jewell NA; Hammond S; Flano E; Durbin RK; García-Sastre A; Durbin JE
    J Virol; 2006 Feb; 80(3):1130-9. PubMed ID: 16414990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors.
    Rosato A; Bronte V; Mandruzzato S; Zambon A; Calderazzo F; Biasi G; Zanovello P; Collavo D
    Int J Cancer Suppl; 1992; 7():24-7. PubMed ID: 1385341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.
    Peebles RS; Hashimoto K; Collins RD; Jarzecka K; Furlong J; Mitchell DB; Sheller JR; Graham BS
    J Infect Dis; 2001 Dec; 184(11):1374-9. PubMed ID: 11709778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses.
    Melendi GA; Bridget D; Monsalvo AC; Laham FF; Acosta P; Delgado MF; Polack FP; Irusta PM
    Virus Genes; 2011 Feb; 42(1):46-54. PubMed ID: 21053062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppressive effect of locally produced interleukin-10 on respiratory syncytial virus infection.
    Ruan Y; Okamoto Y; Matsuzaki Z; Endo S; Matsuoka T; Kohno T; Chazono H; Eiko I; Tsubota K; Saito I
    Immunology; 2001 Nov; 104(3):355-60. PubMed ID: 11722651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.
    Muñoz JL; McCarthy CA; Clark ME; Hall CB
    J Virol; 1991 Aug; 65(8):4494-7. PubMed ID: 2072460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different expression of ICAM-1 and LFA-1 alpha by peripheral leukocytes during respiratory syncytial virus and influenza virus infection in young children.
    Koga M; Matsuoka T; Matsubara T; Katayama K; Furukawa S
    Scand J Infect Dis; 2000; 32(1):7-11. PubMed ID: 10716070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.